May 15, 2013

Pats cut starting defensive tackle after diabetes diagnosis

Kyle Love had lost about 20 pounds before receiving the diagnosis about two weeks ago then gained about half of it back, his agent said.

The Associated Press

FOXBOROUGH, Mass. — The New England Patriots released defensive tackle Kyle Love on Wednesday after he was diagnosed with diabetes.

Love had lost about 20 pounds before receiving the diagnosis about two weeks ago then gained about half of it back, Richard Kopelman, his agent, said.

He said Love has Type 2 diabetes, which is less serious than Type 1, and was working out at Gillette Stadium on Wednesday before being released. The Patriots did not mention the diagnosis in a statement announcing the move.

"They expressed some concern that they didn't know what the recovery time would be and, in their view, didn't want to leave something to chance," Kopelman said. "That's OK. There are 31 other teams in the NFL."

Love started the first 11 games last season next to Vince Wilfork. Brandon Deaderick started the last five but was released on Monday and signed with the Jacksonville Jaguars. In the offseason, the Patriots signed two free-agent defensive tackles, Tommy Kelly and Armond Armstead.

Love joined the Patriots as a rookie free agent out of Mississippi State in 2010 and started 25 of the 41 regular-season games in which he played.

"I think he was, as anybody might be, a bit surprised that a decision would be made in the manner it was, but he completely understands and there's no grudge," Kopelman said.

"He said that after he consulted with doctors, he expects Love to be "100 percent" by the start of training camp.

"I anticipate that he will be on another roster going into training camp and certainly he has every intention of making a 53-man roster," Kopelman said.

NOTE: The Patriots announced the signing of third-round draft choice, DB Duron Harmon of Rutgers. Terms were not disclosed. Harmon, 22, earned All-Big East First Team honors as a junior and senior.


Were you interviewed for this story? If so, please fill out our accuracy form

Send question/comment to the editors

Further Discussion

Here at we value our readers and are committed to growing our community by encouraging you to add to the discussion. To ensure conscientious dialogue we have implemented a strict no-bullying policy. To participate, you must follow our Terms of Use.

Questions about the article? Add them below and we’ll try to answer them or do a follow-up post as soon as we can. Technical problems? Email them to us with an exact description of the problem. Make sure to include:
  • Type of computer or mobile device your are using
  • Exact operating system and browser you are viewing the site on (TIP: You can easily determine your operating system here.)